Saturday, June 12, 2021
Home Biotech

Biotech

New England Cancer Specialists Adopt Deep Lens’ Clinical Trial Matching Solution VIPER™ to Expand Clinical Trial Offering

COLUMBUS, Ohio & SCARBOROUGH, Maine-- Deep Lens and New England Cancer Specialists (NECS) today announced that they have entered into a strategic collaboration to...

Clarify Health Launches Real-World Evidence on Health Disparities

SAN FRANCISCO-- Clarify Health, the leading cloud analytics company delivering real-world insights to healthcare and life sciences organizations, launched new applications of its anonymized...

Nuclera Acquires E Ink Digital Microfluidics Unit

CAMBRIDGE, UK & BILLERICA, Mass.-- Nuclera, a fast-growing biotech company developing enzymatic protein and gene synthesis technologies, and E Ink, the leading innovator of...

908 Devices Launches New Aerosol Module for Handheld MX908

BOSTON-- 908 Devices (NASDAQ:MASS), a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced updates to its...

908 Devices and Bio-Techne Announce Joint Collaboration

BOSTON & MINNEAPOLIS-- 908 Devices (NASDAQ: MASS) and Bio-Techne Corporation (NASDAQ: TECH) today announced a joint collaboration to develop an extended workflow solution for...

Immunomic Therapeutics Announces License Agreement for Cancer Immunotherapy

ROCKVILLE, Md. & CARLSBAD, Calif.-- Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical stage biotechnology company pioneering the study of nucleic acid immunotherapy platforms, announced...

Call for Locally Sourced Medical Devices Answered by Vonco Products

TREVOR, Wis.-- Vonco Products LLC, an industry-leading contract manufacture of liquid-tight medical fluid bags and devices, biohazard transport, and infection prevention PPEs and device...

Waters new BioAccord System Boosts Innovator and Biosimilar Drug Development

MILFORD, Mass.-- Waters Corporation (NYSE:WAT) today introduced a new peptide multi-attribute method (MAM) workflow for the Waters™ BioAccord™ LC-MS System, enabling drug development, manufacturing,...

LabVantage Adds Vendor Validation to Its Software-as-a-Service LIMS

SOMERSET, N.J.-- LabVantage Solutions, Inc., the leading provider of laboratory informatics solutions and services including purpose-built LIMS solutions that allow labs to go live...

Agilent to Acquire Resolution Bioscience, Strengthening Leadership Position in Cancer Diagnostics

SANTA CLARA, Calif.-- Agilent Technologies Inc. (NYSE: A), today announced it has entered into a definitive agreement to acquire Resolution Bioscience Inc., a leader...

Anthony Nolan Cell & Gene Therapy Services and ONK Therapeutics Announce Collaboration

LONDON & GALWAY, Ireland & SAN DIEGO-- Cell therapy company ONK Therapeutics and blood cancer charity Anthony Nolan have entered into a collaboration to...

Cancer Researchers Can Assess Microsatellite Instability (MSI) Through New Lens with Expanded Promega System

MADISON, Wis.-- A new microsatellite instability (MSI) system launched today by Promega Corporation enables cancer researchers to evaluate a new set of unique MSI...
- Advertisment -

Most Read